⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ILMN News
Illumina Inc
Molecular Tumor Board Solutions Market Outlook 2026-2030 & 2035 with Competitor Market Share Data
globenewswire.com
GH
LH
ILMN
Form 8-K
sec.gov
ILMN
LH
PRVA
SNN
Illumina Announces Changes to Board of Directors
prnewswire.com
ILMN
CollectiveMinds LLC Places Robert Hollingsworth, PhD as Chief Scientific Officer of Protillion Biosciences
prnewswire.com
ILMN
PFE
i-Lumen Scientific Receives FDA Approval of IDE to Initiate U.S. Enrollment in i-SIGHT2 Clinical Study for dry AMD USA - English USA - English
prnewswire.com
ILMN
i-Lumen Scientific Receives FDA Approval of IDE to Initiate U.S. Enrollment in i-SIGHT2 Clinical Study for dry AMD
prnewswire.com
ILMN
Artificial Intelligence in Oncology: Assessment of Market Opportunities by Region and Market, 2026-2030 - North America Leads but Asia-Pacific is Emerging Fast
globenewswire.com
ILMN
IBM
GEHC
NVDA
Dreamday Appoints Veronica Gauthier as Senior Vice President of Growth to Scale Performance Marketing Capabilities and Revenue
prnewswire.com
UBER
TGT
AMZN
FARM
ILMN
Global Artificial Intelligence (AI) in Precision Medicine Market to Attain USD 10.32 Billion by 2032, Witnessing a CAGR of 31.35%, Says MarkNtel Advisors
prnewswire.com
ILMN
GH
Robert Hollingsworth has been appointed as the Chief Scientific Officer of Protillion Biosciences
prnewswire.com
PFE
ILMN